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Abstract
The third-generation ionic liquids (ILs), which are being used to produce double 
active pharmaceutical ingredients (d-APIs) with tunable biological activity along with 
novel performance, enhancement, and delivery options, have been revolutionizing the 
area of drug discovery since the past few decades. Herein we report the in vitro anti-
bacterial and anti-inflammatory activity of benzalkonium ibuprofenate (BaIb) that are 
being used as in-house d-API, with a particular focus on its interaction with respective 
protein target through molecular docking study. The evaluation of the biological activ-
ity of BaIb with the antibacterial and anti-inflammatory target at the molecular level 
revealed that the synthesized BaIb could be designed as a potential double active drug 
since it retains the antibacterial and anti-inflammatory activity of its parent drugs, 
benzalkonium chloride (BaCl) and sodium ibuprofenate (NaIb), respectively.
Keywords: benzalkonium ibuprofenate, double active pharmaceutical ingredient, 
molecular docking studies, anti-inflammatory, antibacterial activities
1. Introduction
In the pharmaceutical field, ionic liquids (ILs) by salification of drugs were 
widely applied to improve the performance of drugs on its oral administration, 
especially, their solubility, bioavailability, and stability. The research on the antimi-
crobial activity of ILs is a growing field because of its unprecedented flexibility for 
chemical diversity in a severely drained arsenal of antimicrobial. The third-gener-
ation ionic liquids give us the freedom to tune the biological properties in addition 
to its physical and chemical properties. The proper selection of ions with synergetic 
effects may result in the formation of double active pharmaceutical ingredient 
(d-API). Thus the d-APIs are composed of asymmetric organic ions, which prevent 
the formation of the stable crystal lattice and are liquid at unusually low tempera-
tures. Such d-APIs can be used for the ailment situations where the two activities are 
required. This strategy will reduce the excess in taking of unwanted chemicals and 
will enhance the solubility and bioavailability [1, 2].
Benzalkonium ibuprofenate (BaIb) is a double active pharmaceutical ingredient 
designed by combining benzalkonium cations with ibuprofen. Benzalkonium chloride 
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(BaCl) is a potential antibacterial drug and sodium ibuprofen is a prospective anti-
inflammatory drug [3]. It is important to evaluate the pharmaceutical profiles of the 
d-API to confirm the retainity of the biological activities of the parent drugs. We have 
synthesized a d-API, benzalkonium ibuprofenate, carried out its quantum mechanical 
calculations using density functional theory, characterized different experimental 
techniques, and reported glass-forming ability in earlier works [4, 5]. Now, in this 
work, the biological evaluations, in particular, the antibacterial and anti-inflamma-
tory activities, were performed and the results with the activity of parent drugs, BaCl 
and sodium ibuprofenate (NaIb), compared. The molecular docking of all the samples 
was done to get a better understanding of the mode of interaction between the drugs 
and respective targeted proteins and to trace their binding pores and cites.
2. Materials and method
2.1 Materials
The benzalkonium chloride and sodium ibuprofenate were purchased from 
Sigma-Aldrich (USA). Cell culture plastic flasks, test tubes, and culture plates were 
purchased from Borosil (India).
2.2 Experimental
2.2.1 Synthesis
The double active pharmaceutical ingredient, benzalkonium ibuprofenate, 
was synthesized using stoichiometric metathesis reaction. Solid (1 mmol) BaCl 
and NaIb were dissolved in 50 mL distilled water, each taken in two beakers and 
stirred separately with gentle heating (40–60°C). Then the two solutions were 
mixed together and again stirred for another 30 min with heating (around 80°C) 
and then cooled to room temperature. 60 mL of chloroform was added to separate 
the organic and inorganic part; then the chloroform phase was washed with cold 
distilled water until it removes the inorganic salt completely. AgNO3 test was used to 
confirm the absence of chloride anions in the product. This is followed by continu-
ous washing of the chloroform phase with deionized (DI) water until the water 
washings tested negative for NaCl or NaBr via AgNO3 test. The chloroform was then 
evaporated using rotary evaporator, and the BaIb was dried under high vacuum for 
12 h with gentle heating (50–60°C) [4, 6].
The double active pharmaceutical ingredient, BaIb was characterized well using 
Nuclear Magnetic Resonance using Bruker Avance III, 400MHzwith a 9.4 Tesla 
super-conducting magnet in an operating temperature at 309 K, Fourier transform 
infrared spectroscopy JASCO FTIR-4100 spectrophotometer, Fourier Transform-
Raman spectroscopy and UV–visible spectroscopy using Jasco UV–Visible 
Spectrophotometer model V-550 (USA) and are reported in earlier works [4, 5].
2.2.2 Biological evaluation
2.2.2.1 Antibacterial activity
The synthesized double active pharmaceutical ingredient BaIb was screened 
against Gram-negative bacteria to confirm the retainity of the biological activity of 
its parent drug BaCl, which is a potential germicide. For this study, we have chosen 
Pseudomonas aeruginosa and E. coli as Gram-positive, while DMSO is considered as 
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Gram-negative. Paper disk method was used for the in vitro analysis. The experi-
ment was started with the preparation of nutrient agar (28 g in 100 mL) and was 
sterilized by autoclaving. This nutrient agar media was cooled without solidifying 
and incubated overnight. P. aeruginosa and E. coli were prepared. 15–20 mL of this 
media was poured into sterilized Petri plate and allowed to solidify. Then sterilized 
disks were placed in this solidified agar plate; each plate contains three disks. 10 μL 
negative controls on to one disk, 10 μL standard parent drugs on to the second disk, 
and 10 μL samples on to the third disk were added and appropriately labeled. After 
incubating the Petri dishes in 310 K for 24 h, the plates were checked for the zone of 
inhibition, and the zone diameter was measured using a scale [4, 7].




 × 100                           (1)
2.2.2.2 Anti-inflammatory activity
2.2.2.2.1 In chick albumin
The anti-inflammatory activity of BaIb and NaIb was done using an egg albu-
min. For this, a reaction mixture of 5 mL was made with fresh hen’s egg (0.2 mL) 
and phosphate buffer saline with pH = 6.4 of 2 mL with varying concentrations 
of extract for preparing the concentrations of 100, 200, 300, 400, and 500 μg/
mL. The same steps were repeated for the preparation of double distilled water, 
which served as control. Then the prepared mixtures were incubated in BOD incu-
bator (Labline Technologies, India) at 210 ± 2 K for 15 min; after that, it is heated to 
343 K and was hold for 5 min. The absorbance was measured after incubating using 
Shimadzu (Japan), UV 1800 at 660 nm. At the final concentration of 100, 200, 300, 
400, and 500 μg/mL, acetyl salicylic acid was used as reference drug. The protein 
denaturation inhibition percentage was calculated using the following formulae:
                                  %inhibition =   Abs control−  Abs test   ____________
 Abs control 
 × 100                                 (2)
2.2.2.2.2 In human serum albumin
In addition, the synthesized drug BaIb was screened for its anti-inflammatory 
activity, and its efficiency with the parent drug NaIb and drug diclofenac was 
compared. For this, blood samples from a healthy donor (male) were collected and 
mixed with sterilized Alsever’s solution before centrifuging it at 3000 rpm. The 
suspension of packed cells was made with isoline. This suspension with phosphate 
buffer, hyposaline, was mixed with diclofenac at varying concentration, where the 
distilled water is taken as control while diclofenac as standard. Then the mixtures 
were incubated for 30 min at 303 K and centrifuged. Spectrophotometric analysis 
was used for hemolysis at 560 nm and its percentage recorded [4, 8, 9].
2.3 Computational
The input structures of BaCl (PubChem: 2330), NaIb (PubChem: 5338317), 
and BaIb (PubChem: 86612072) were taken from the PubChem database [9] 
and optimized using density functional theory with B3LYP level of theory and 
631-G+(d,p) [10] basis sets using Gaussian software packages [11]. Further, the 
molecular docking was also conducted using Schrodinger Maestro software package 
[10]. The optimized structures and downloaded Protein Data Bank (PDB) files [12] 
of proteins were used for molecular docking studies.
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The Schrodinger’s Glide module was used for docking analysis of the present 
work. Glide offers the full range of speed vs. accuracy options, from the HTVS 
(high-throughput virtual screening) mode for efficiently enriching million com-
pound libraries, to the SP (standard precision) mode for reliably docking tens to 
hundreds of thousands of ligand with high accuracy, and to the extra precision (XP) 
mode where further elimination of false positives is accomplished by more exten-
sive sampling and advanced scoring, resulting in even higher enrichment. Many 
researchers carried out extensive comparisons of several docking programs and 
scoring functions using an extensive data set of pharmaceutically attractive targets 
and active compounds [13–18]. All the study leads to the same result that Glide XP 
methodology was shown to yield enrichments superior to the alternative methods 
consistently. Glide SP scoring also shows improvement as compared to the scoring 
in GOLD and DOCK. The drawbacks of Glide come from the fact that it’s increas-
ing computational time. From computational efficiency, the CPU time required on 
average for Glide XP calculations (7.0 min per ligand) is larger than other methods 
except for the most accurate version of Goldscore (8.5 min per ligand). This extra 
cost for Glide XP is the trade-off for the higher enrichment factors obtained. Glide 
SP delivers the second best overall enrichment performance while providing a 
considerable speedup (0.42 min per ligand) as compared to all approaches except 
for the fast version of GOLD Chemscore setting.
2.3.1 Molecular docking studies
The structure-based drug design always promotes the in silico method for 
molecular docking before going to lab screening. In silico methods can site the bind-
ing pores and predict the mechanism of protein-ligand interactions as well as target 
binding.
Moreover, the analysis and interpretation of the binding behavior play a crucial 
role in rational drug designs and in elucidating fundamentals of biochemical 
processes. The antibacterial activity of BaCl and BaIb was studied using LpxC 
enzymes since the enzyme LpxC places an important role in the lipid A biosyn-
thesis. Lipid A acts as a hydrophobic membrane of lipopolysaccharide (LPS) in 
the outer leaflet of the outer membrane of Gram-negative bacteria; however, the 
bacteria is with a defective lipid. A synthesis reduces its hydrophobicity and shows 
increased membrane permeability, which in turn increase the sensitivity to the 
antibiotics, and hence, it results in cell death. For this work, we have selected LpxC 
from Escherichia coli and P. aeruginosa. In the same way, the targeted protein for 
the anti-inflammatory activity of NaIb and BaIb were studied using human serum 
albumin (HSA).
Thus the structures of proteins used in this work were downloaded from the 
Protein Data Bank [12]. The detailed information of the selected proteins, their 
PDB IDs, inbuilt inhibitor, X-ray resolution, etc., were given in Table 1. Molecular 
docking study has been carried out by the Glide docking program [19–21] provided 
by Schrodinger suite. Protein preparation is done by using the Protein Preparation 
Wizard module of Glide [22, 23]. Initially, all the protein structures must be pre-
processed to be used as a receptor for docking. Some of the typical operations in 
preprocessing include (i) addition of hydrogen atoms, (ii) assignment of atomic 
charges, and (iii) elimination of water molecules that are not involved in ligand 
binding. Missing chains and loops can also be added if necessary. Preprocessed 
protein was optimized with PROPKA and then minimized with OPSL3 force field 
function, which is followed by a convergence of heavy atoms of RMSD 0.3 Å.
Then, the Glide’s receptor grid generation wizard was used to generate a three-
dimensional (3D) grid with a maximal size of 20 × 20 × 20 Å with 0.5 Å spacing. 
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There is enough option to apply any constraints such as precision constraints, 
H-bond constraint, etc., in the receptor grid generation wizard. At last, flexible 
docking was performed with extra precision docking mode in Glide docking 
module.
3. Results and discussions
3.1 Antibacterial activities of BaCl and BaIb
3.1.1 In vitro studies
As we know, benzalkonium chloride is a prominent germicide widely used in 
medicinal chemistry [24]. It is mandatory to confirm the retainity of BaCl’s anti-
bacterial effect in the synthesized d-API, BaIb. The inhibition zone method using 
agar diffusion was used to screen the antibacterial activity of the prepared as well as 
parent drug against P. aeruginosa and E. coli bacterial strains [25]. The percentage of 
inhibition and its diameter are listed in Table 2. The results emphasized that BaIb 
retains the antibacterial activity of parent drug BaCl, though it had less inhibitory 
action against E. coli and P. aeruginosa than the parent drug [25].
3.1.2 Molecular docking studies with LpxC (E. coli)
Here, molecular docking of the parent and daughter drugs, BaCl and BaIb with 
Escherichia coli LpxC/LPC-009 complex, has been employed to trace its binding 
pore and binding affinity. The docking scores and binding free energies of lowest 
energy pose of its inbuilt inhibitor, 3p3 and the samples under study, BaCl, and BaIb 
in active sites on chain A of the LpxC/LPC-009 X-ray crystal structures have been 
computed after deleting the unwanted ligands and amino acids (So4 at 501, 502, 
504, 505, 506; dimethyl sulfide (DMS) at 701; and UKW) using Schrodinger Glide 
module and are given in Table 3. The docking result points out that the drugs BaCl 
and BaIb show considerable binding affinity scores compared to the inbuilt ligand. 
However, interestingly the d-API BaIb exhibits high docking score compared to the 
parent drug BaCl, which emphasize that the interaction between the ligand and 
protein increases on double active formation with ibuprofen.
Figure 1 demonstrates the three-dimensional protein-ligand interaction of the 
three samples under study in the dynamic site of LpxC/LPC-009 obtained from 
graphical interface Maestro. All the ligands are found to be buried in the deep bind-
ing pocket of LpxC/LPC-009 in the same way. The d-API BaIb interacts with the 









1 LpxC Escherichia 
coli
3P3G 3p3 1.65 Å BaCl, 
BaIb
Antibacterial
2 LpxC Pseudomonas 
aeruginosa
5U3B NVS 2.00 Å BaCl, 
BaIb
Antibacterial
3 HSA Homo 
sapiens





Detailed information regarding the proteins under study.
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In addition to the 3D binding orientations of the ligands in the protein, the dock-
ing results provide further insights into selective interactions of the ligands with the 
E. coli LpxC in the 2D image, as shown in Figure 2. The ligands were encompassed 
by active site amino acids THR191, PHE192, SER211, PHE212, CYS214, LYS239, 
HIS238, HIS265, etc., of LpxC. The co-crystallized ligand 3P3 occupied the deep 
cavity by forming three hydrogen bonds and one π-π interaction with active site 
amino acid PHE212. Though the parent ligand BaCl occupied the deep cavity of 
Compound Schrodinger software





Docking scores and binding free energies of inbuilt inhibitor 3P3, BaCl, and BaIb to the LpxC/LPC-009 using 
Schrodinger Maestro software.
The diameter of zone of inhibition (mm) Percentage of inhibition (%)
E. coli P. aeruginosa E. coli P. aeruginosa
Standard BaCl 19 38 Standard BaCl 21.11 42.22
Sample BaIb 14 31 Sample BaIb 15.55 34.44
Negative (DMSO) 0 0 Negative (DMSO) 0 0
Table 2. 
Preliminary in vitro antibacterial screening activity of BaIb.
Figure 1. 
Three-dimensional (3D) protein-ligand interactions diagram using Schrodinger software (I) with LpxC 
protein of E. coli using (a) inbuilt ligand 3P3, (b) parent ligand BaCl, and (c) double active pharmaceutical 
ingredient BaIb; (II) with LpxC (P. aeruginosa) using (a) inbuilt ligand 3P3, (b) parent ligand BaCl, and 
(c) double active pharmaceutical ingredient BaIb; and (III) with human serum albumin using (a) inbuilt 
ligand ibuprofen and (b) double active pharmaceutical ingredient BaIb.
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LpxC with the support of salt bridges between them, the daughter ligand BaIb 
formed one hydrogen bond with the active amino acid LYS239.
Despite the binding energy and docking score difference between parent and 
daughter drugs, BaCl and BaIb were well occupied in the binding site of the LpxC 
protein as similar to the native ligand 3P3 by forming a hydrogen bond with active 
site amino acids. Besides, the binding energy and docking score emphasize that 
the d-API has a higher binding affinity with LpxC than the parent drug BaCl. This 
indicates that BaIb can be considered as a potential inhibitor of LpxC protein with 
antibacterial activity.
3.1.3 Molecular docking studies with LpxC (P. aeruginosa)
Here, molecular docking of the parent and daughter drugs, BaCl and BaIb with 
LpxC protein of Pseudomonas aeruginosa, has been employed to trace the nature of 
its binding interaction and binding affinity value. The docking scores and binding 
free energies of lowest energy pose of its inbuilt inhibitor, NVS-LpxC-01 and the 
samples under study, BaCl, and BaIb in active sites on chain B of the NVS-LpxC 
X-ray crystal structures, have been computed after deleting the unwanted ligands 
and amino acids and including the Zn2+ using Schrodinger Maestro software and 
are given in Table 4. The docking result points out that the drugs BaCl and BaIb 
show considerable binding affinity scores compared to the inbuilt ligand. However, 
Figure 2. 
Schematic representations of ligand-protein interaction and binding interaction using stick mode. (a) 3P3 with 
LpxC, (b) BaCl with LpxC, and (c) BaIb with LpxC.
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interestingly the d-API BaIb exhibits high docking score compared to the parent 
drug BaCl, which emphasizes that the interaction between the ligand and protein 
increased on double active formation with ibuprofen.
Figure 1 demonstrates the three-dimensional protein-ligand interaction of three 
samples under study in the active site of LpxC in complex obtained from graphical 
interface Maestro. All the ligands are found to be buried in the deep binding pocket 
of LpxC in the complex in an indistinguishable way. The d-API BaIb interact with 
the active site’s amino acids of the protein by H-bonding, which is depicted in red 
and dotted lines.
Compound Schrodinger software





Docking scores and binding free energies of inbuilt inhibitor NVS, BaCl, and BaIb to the LpxC/LPC-009 using 
Schrodinger Maestro software.
Figure 3. 
Schematic representations of ligand-protein interaction and binding interaction using stick mode. (a) 3P3 with 
LpxC, (b) BaCl with LpxC, and (c) BaIb with LpxC using Schrodinger software.
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In addition to the 3D binding orientations of the ligands in the protein, the dock-
ing results provide further insights into selective interactions of the ligands with 
the Pseudomonas aeruginosa LpxC in the 2D image as shown in Figure 3. The ligands 
were surrounded by active site amino acids THR190, GLY192, PHE191, SER211, 
PHE193, MET194, ASP196, DLE197, LEU200, ARG201, VAL216, etc., of LpxC. The 
co-crystallized ligand NVS occupied the deep cavity by forming five hydrogen 
bonds in addition to its salt bridge. Though the parent ligand BaCl occupied the 
deep cavity of LpxC with the support of salt bridges between them, the daughter 
ligand BaIb formed one hydrogen bond with the active amino acid LYS238 and a 
π-cation interaction with active site amino acid PHE191.
Despite the binding energy and docking score difference of parent as well as the 
daughter drugs, BaCl and BaIb were well occupied in the binding site of the LpxC 
protein as similar to the native ligand NVS with hydrogen bonding with active site 
amino acids. Also, the binding energy and docking score emphasize that the d-API 
has a higher binding affinity with LpxC than the parent drug BaCl. This indicates 
the BaIb can be considered as a potential inhibitor of LpxC protein with antibacte-
rial activity.
3.2 Anti-inflammatory activities of NaIb and BaIb
3.2.1 In vitro studies using chick albumin
The anti-inflammatory properties of the synthesized drug BaIb and parent drug 
NaIb were studied in chick albumin membrane. Figure 4 depicts the bar diagram 
of the percentage inhibition of inflammation against the concentration of NaIb and 
BaIb. Sample NaIb and BaIb have almost the same inhibitory activity in all concen-
tration, which is around 95%. Thus from this analysis, one can confirm that BaIb 
retains the anti-inflammatory activity of NaIb and states.
3.2.2 In vitro studies using human serum albumin
The anti-inflammatory properties of the synthesized drug BaIb, parent drug 
NaIb, and drug diclofenac as standard samples were given in Table 5. Among 
samples provided, diclofenac shows maximum inhibitory activity, whereas the 
NaIb and BaIb are less active than the reference compound, but still, its activity is 
significant as an inflammatory agent. This fact suggests that the anti-inflammatory 
activity of NaIb was retained in the double active pharmaceutical ingredient. Thus 
the in vitro study confirms that the synthesized BaIb is a double active pharmaceu-
tical ingredient by retaining the biological activities of the parent drugs.
3.2.3 Molecular docking studies of NaIb and BaIb with HSA
Here, molecular docking of the parent and daughter drugs, NaIb and BaIb, 
respectively, with human serum albumin complex has been employed to analyze its 
binding mode and binding affinity value. The docking scores and binding free ener-
gies of lowest energy pose of its inbuilt inhibitor, ibuprofen and the BaIb in active 
sites on chain A of the 2BXG X-ray crystal structures, have been computed after 
deleting the unwanted ligands and amino acids using Schrodinger Maestro software 
and are given in Table 6. The docking result points out that the drugs ibuprofen 
and BaIb show considerable binding affinity scores compared to the inbuilt ligand. 
However, interestingly the d-API BaIb exhibited almost similar docking score to 
the parent drug Ib, which emphasizes that the interaction between the ligand and 
protein is still functional on double active formation with ibuprofen.
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Figure 1 demonstrates the three-dimensional protein-ligand interaction of three 
samples under study in the dynamic site of 2BXG obtained from graphical interface 
Maestro. All the ligands are found to be well occupied in the deep binding pocket of 
2BXG in the same way. The d-API BaIb interact with the active site’s amino acids 
of the protein by H-bonding, which is depicted in red and dotted lines. Interaction 
of amino acids at the active site of HAS with the studied compound is displayed in 
the 2D image (Figure 5). The ligands were encircled by amino acids like SER480, 
LBU481, VAL482, ASN483, PHE205, ARG209, ALA210, ALA213, etc., of HSA. The 
co-crystallized ligand ibuprofen occupies the deep cavity by forming three hydro-
gen bonds with active sites of amino acids SER480, LBU481, VAL482, and one 
π-anion interaction with active site amino acid LYS351. The daughter ligand BaIb 
forms only one hydrogen bond with the amino acid LYS239.
Despite the binding energy and docking score difference of parent as well as the 
daughter drug, the daughter drug, BaIb, was well occupied in the binding site of the 
Percentage of inhibition of hemolysis (%)
Diclofenac 92.16
Standard sample NaIb 88.47
Sample BaIb 88.59
Table 5. 
Preliminary in vitro anti-inflammatory properties of BaIb.
Figure 4. 
Plot of percentage inhibition of inflammation against the concentration of NaIb and BaIb studied in chick 
albumin membrane.
Compound Schrodinger software




Docking scores and binding free energies of inbuilt inhibitor ibuprofen and BaIb to the 2BXG using Schrodinger 
Maestro software.
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HSA protein as similar to the native ligand ibuprofen by forming a hydrogen bond 
with active site amino acid.
4. Conclusions
In this work, the biological evaluations of a synthesized double active pharma-
ceutical ingredient BaIb were done to confirm the retainity of the biological activi-
ties of its parent drugs and to elucidate information regarding its potential activities 
against their respective ailments. Further molecular docking studies were done to 
get a better understanding about the mode of interaction of the parent as well as 
daughter drugs with the targeted proteins and trace out the binding pore and cites 
in the targeted proteins.
The in vitro studies revealed that the synthesized BaIb could be designed as 
a potential double active drug since it retained the antibacterial activity of its 
parent BaCl with considerable inhibitory action against E. coli and P. aeruginosa 
compared to the parent drug. The binding energy and docking score of BaCl and 
BaIb again confirm that the prepared d-API BaIb docks well into the LpxC pro-
teins of E. coli and P. aeruginosa with high docking and Glide score compared to 
the parent drug BaCl.
Similarly, the results from both in vitro and in silico method emphasize that 
the prepared d-API retained the anti-inflammatory action of its parent NaIb and 
bound well to the deep pocket of the active site in the human serum albumin. Thus, 
in total, one can conclude that the prepared BaIb can be used as a potential double 
active drug with antibacterial and anti-inflammatory actions.
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